TreatmentStem Cells


Cancer Gene Ther, May 1, 2003; 10(5): 396-402. (Laboratory Investigation)


Abstract

Transplantation of prodrug-converting neural progenitor cells for brain tumor therapy

Vincenza Barresi, Natale Belluardo, Simonetta Sipione, Giuseppa Mudò, Elena Cattaneo and Daniele Filippo Condorelli

Department of Chemical Sciences, Section of Biochemistry and Molecular Biology, University of Catania, Italy [V.B., D.F.P.]; Department of Experimental Medicine, University of Palermo, Italy [N.B., G.M.]; Department of Pharmacological Sciences, University of Milan, Italy [S.S., E.C.]. Correspondence to: Professor DF Condorelli, Sezione di Biochimica e Biologia Molecolare, Dipartimento di Scienze Chimiche, Facoltà di Medicina, Università di Catania, Viale A. Doria, 6, 95125 Catania, Italy. E-mail: condorda@mbox.unict.it.
Received 22 November 2002

Since neural progenitor cells can engraft stably into brain tumors and differentiate along the neuronal and glial line, we tested the hypothesis that transplanted cytosine deaminase (CD)-expressing ST14A cells (an immortalized neural progenitor cell line) can convert locally 5-fluorocytosine (5-FC) into 5-fluorouracil (5-FU) and produce a regression of glioma tumors. 
ST14A, retrovirally transduced with the E. coli CD gene, showed a strong bystander effect on glioma cells as assessed by in vitro assay. 
Intracerebral injection of C6 glioma cells generated a rapidly growing tumoral mass. 
DiI prelabeled ST14A, coinjected into the rat brain with C6 glioma cells, survived in the tumoral mass up to 10 days and their number was not affected by in vivo 5-FC treatment. 
In contrast, a significant decrease of the glioma tumoral mass (-50%) was observed in 5-FC-treated rats. 
5-FC had no effect on the tumor in the absence of CD-expressing ST14A cells. 
Our results support the feasibility of systems based on intratumoral transplantation of prodrug-converting cells for brain tumor therapy.

Keywords: gene therapy; cytosine deaminase; glioma; neural progenitor cells

© 2003 Nature Publishing Group

Source: http://www.nature.com/cgi-taf/DynaPage.taf?file=/cgt/journal/v10/n5/abs/7700580a.html&dynoptions=doi1092205197



 

HOME | Detection | Diagnosis | Epidemiology | Etiology & Pathogenesis | Integrative Medicine | Overall Mngt & Case Reports | Prevention | Prognosis | Psychosocial Aspects | Treatment 
About BrainLife
| BL Newsletter |
Children's Corner | E-mail Alerts | Journals | Patients & Caregivers | Search | Stem Cells | WHO Classification | SITEMAP